Answer
Tasigna (nilotinib) is indicated for newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukaemia (CML) in the chronic phase in adults and children.
Sources for this answer
- Tasigna 50mg, 150mg and 200 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 39Document updated
Sources checked